Stille AB Just Missed EPS By 32%: Here's What Analysts Think Will Happen Next

It's shaping up to be a tough period for Stille AB (STO:STIL), which a week ago released some disappointing quarterly results that could have a notable impact on how the market views the stock. It looks like quite a negative result overall, with both revenues and earnings falling well short of analyst predictions. Revenues of kr129m missed by 11%, and statutory earnings per share of kr1.63 fell short of forecasts by 32%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Stille after the latest results.

We've discovered 1 warning sign about Stille. View them for free.

Taking into account the latest results, the most recent consensus for Stille from dual analysts is for revenues of kr612.1m in 2025. If met, it would imply a notable 9.4% increase on its revenue over the past 12 months. Per-share earnings are expected to bounce 56% to kr10.50. In the lead-up to this report, the analysts had been modelling revenues of kr627.5m and earnings per share (EPS) of kr10.50 in 2025. So it looks like the analysts have become a bit less optimistic after the latest results announcement, with revenues expected to fall even as the company is supposed to maintain EPS.

See our latest analysis for Stille

The average price target was steady at kr274even though revenue estimates declined; likely suggesting the analysts place a higher value on earnings.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Stille's past performance and to peers in the same industry. We would highlight that Stille's revenue growth is expected to slow, with the forecast 13% annualised growth rate until the end of 2025 being well below the historical 30% p.a. growth over the last five years. Compare this to the 61 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 14% per year. So it's pretty clear that, while Stille's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Sadly, they also downgraded their revenue forecasts, but the business is still expected to grow at roughly the same rate as the industry itself. With that said, earnings are more important to the long-term value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2027, which can be seen for free on our platform here.

It is also worth noting that we have found 1 warning sign for Stille that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.